3/23/2016 4:09:35 PM
StemCells Q4 Loss/share $0.08 Vs. Loss $0.15 Year Ago
3/9/2016 9:26:35 AM
StemCells Prices Public Offering Of Common Stock And Warrants To Raise $8.1 Mln
1/11/2016 8:08:07 AM
StemCells Names Ian Massey To Succeed Martin McGlynn As CEO
12/23/2015 8:13:26 AM
StemCells Trading Expected To Resume At 8:35 AM ET
12/23/2015 8:07:01 AM
StemCells Announces Strategic Realignment; Plans Workforce Reduction Of 25%
12/23/2015 8:02:58 AM
StemCells Trading Halted; Pending News
11/2/2015 4:07:00 PM
StemCells Posts Q3 Loss/share Of $0.09 Vs. Loss $0.04 Year Ago
8/6/2015 4:22:35 PM
StemCells Q2 Non-GAAP Net Loss $7.82 Mln Or 0.08 Per Share
8/6/2015 4:21:45 PM
StemCells Q2 Non-GAAP Net Loss $7.82 Mln Or (0.08 Per Share
8/6/2015 8:47:07 AM
Inogen Names Scott Greer Independent Director, Effective August 3